ES2064288A1 - Composition for the treatment of skin disorders, preparation thereof and use thereof - Google Patents

Composition for the treatment of skin disorders, preparation thereof and use thereof

Info

Publication number
ES2064288A1
ES2064288A1 ES09301511A ES9301511A ES2064288A1 ES 2064288 A1 ES2064288 A1 ES 2064288A1 ES 09301511 A ES09301511 A ES 09301511A ES 9301511 A ES9301511 A ES 9301511A ES 2064288 A1 ES2064288 A1 ES 2064288A1
Authority
ES
Spain
Prior art keywords
preparation
composition
treatment
ketoconazole
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301511A
Other languages
Spanish (es)
Other versions
ES2064288B1 (en
Inventor
Ornosa Enrique Viayna
Ornosa M Pilar Viayna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9301511A priority Critical patent/ES2064288B1/en
Publication of ES2064288A1 publication Critical patent/ES2064288A1/en
Application granted granted Critical
Publication of ES2064288B1 publication Critical patent/ES2064288B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition for the treatment of skin disorders, preparation thereof and use thereof. It includes ketoconazole as the active principle. It is characterized in that as technological coadjuvant it includes triamcinolone acetonide and excipient. It advantageously includes 2% ketoconazole and 0.1% triamincinolone acetonide. It is presented in the form of a lotion for topical use, by the addition of a hydroalcoholic excipient which comprises 60% by volume of 96degree alcohol, 30% by volume of distilled water and 10% by volume of propylene glycol. The preparation of the composition is characterized in that it involves the dissolution, in a topaz glass bottle, of 96degree alcohol with ketoconazole and triamcinolone acetonide and dilution by means of distilled water, until the alcohol is 70degree, adding propylene glycol and placing in a water bath at a maximum temperature of 75degreeC. A lotion is obtained for the topical treatment of pityriasis, seborrhoeic dermatitis and psoriasis which does not exhibit side effects.
ES9301511A 1993-07-06 1993-07-06 COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS, THEIR PREPARATION AND USE. Expired - Fee Related ES2064288B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301511A ES2064288B1 (en) 1993-07-06 1993-07-06 COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS, THEIR PREPARATION AND USE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301511A ES2064288B1 (en) 1993-07-06 1993-07-06 COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS, THEIR PREPARATION AND USE.

Publications (2)

Publication Number Publication Date
ES2064288A1 true ES2064288A1 (en) 1995-01-16
ES2064288B1 ES2064288B1 (en) 1995-08-01

Family

ID=8282457

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301511A Expired - Fee Related ES2064288B1 (en) 1993-07-06 1993-07-06 COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS, THEIR PREPARATION AND USE.

Country Status (1)

Country Link
ES (1) ES2064288B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2119726A1 (en) * 1997-03-20 1998-10-01 Reolid Manuel Sanchez Composition of a product for application on the body.
US8026238B2 (en) 1997-10-17 2011-09-27 Stiefel Research Australia, Pty Ltd Topical antifungal composition
ES2674130A1 (en) * 2016-12-27 2018-06-27 Laboratorios Viñas S.A. Hydroalcoholic pharmaceutical composition for topical use for external otitis treatment and corresponding method and use (Machine-translation by Google Translate, not legally binding)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491588A (en) * 1982-03-31 1985-01-01 University Of Tennessee Research Corporation Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
US4942162A (en) * 1982-03-31 1990-07-17 University Of Tennessee Research Corporation Topical treatment of seborrheic dermatitis with ketoconazole
EP0396184A2 (en) * 1989-05-03 1990-11-07 Janssen Pharmaceutica N.V. Use of ketoconazole and a retinoid for the treatment of acne vulgaris

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491588A (en) * 1982-03-31 1985-01-01 University Of Tennessee Research Corporation Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics
US4942162A (en) * 1982-03-31 1990-07-17 University Of Tennessee Research Corporation Topical treatment of seborrheic dermatitis with ketoconazole
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
EP0396184A2 (en) * 1989-05-03 1990-11-07 Janssen Pharmaceutica N.V. Use of ketoconazole and a retinoid for the treatment of acne vulgaris

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2119726A1 (en) * 1997-03-20 1998-10-01 Reolid Manuel Sanchez Composition of a product for application on the body.
US8026238B2 (en) 1997-10-17 2011-09-27 Stiefel Research Australia, Pty Ltd Topical antifungal composition
US8586066B2 (en) 1997-10-17 2013-11-19 Delcor Asset Corporation Topical antifungal composition
ES2674130A1 (en) * 2016-12-27 2018-06-27 Laboratorios Viñas S.A. Hydroalcoholic pharmaceutical composition for topical use for external otitis treatment and corresponding method and use (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
ES2064288B1 (en) 1995-08-01

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
EP0232982A3 (en) Treatment of skin disorders
FI881736A0 (en) Use of beer mash extract for the manufacture of cosmetic products, cosmetic product and beer mash extract
ATE137665T1 (en) COSMETIC PRODUCT
EP0093186A1 (en) Pharmaceutical preparation for the topical treatment of acne
GR3027749T3 (en) Cosmetic or pharmaceutical composition for topical application active against free radicals.
DE68912195T2 (en) Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis.
DK0631772T3 (en) Retinoid-containing composition
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
KR960010002A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
DE69412072D1 (en) Use of a phenolic diterpene for the manufacture of a composition for therapeutic use on skin
HK1055079A1 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
ES2363688T3 (en) COSMETIC COMPOSITIONS AND PROCEDURE TO PRODUCE A SENSORY REFRESHING SENSATION.
KR910005877A (en) Topical compositions containing depolymerized deoxyribonucleic acid to alleviate unsightly defects on the facial epidermis and skin areas of the body
ES2093102T3 (en) METHOD THAT ALLOWS TO REDUCE THE IRRITATING PROPERTIES OF A COSMETIC COMPOSITION.
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
ES2064288A1 (en) Composition for the treatment of skin disorders, preparation thereof and use thereof
EP0046594A3 (en) Therapeutic method and pharmaceutical composition
CS275816B6 (en) Cosmetic preparation for use on greasy skin
EP0357646A4 (en) Treatment of aged skin with oral 13-cis-retinoic acid
TW328049B (en) Penciclover/propylene glycol composition
DE3570970D1 (en) Antiseptic product and method for manufacturing this product
ITRM930034A0 (en) ACTIVE AGENT TO REDUCE THE BLOOD LEVEL OF GLUCOCORTICOIDS AND PREVENT BRAIN DISORDERS DUE TO STRESS AND SENILITY.
Faergemann Pharmacology and Treatment Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole‐hydrocortisone (Daktacort), miconazole and hydrocortisone
HUP0101497A2 (en) Cosmetic preparations

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060707